Hemostemix Inc. (TSXV:HEM)
Canada · Delayed Price · Currency is CAD 0.0700
-0.0050 (-6.67%)
Sep 18, 2026, 10:12 AM EST
Hemostemix Market Cap
Hemostemix has a market cap or net worth of CAD 14.8 million as of September 18, 2026. Its market cap has decreased by -19.43% in one year.
Market Cap
14.80M
Enterprise Value
18.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
ChartMarket Cap Chart
Since November 28, 2014, Hemostemix's market cap has decreased from 48.88M to 14.80M, a decrease of -69.72%. That is a compound annual growth rate of -9.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 14.80M | -15.77% |
| Dec 31, 2025 | 17.57M | 3.39% |
| Dec 31, 2024 | 17.00M | 178.71% |
| Dec 29, 2023 | 6.10M | -55.27% |
| Dec 30, 2022 | 13.63M | 44.06% |
| Dec 31, 2021 | 9.46M | -70.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| The More Life Company | 27.42M |
| Pharmala Biotech Holdings | 27.42M |
| Devonian Health Group | 23.98M |
| Alzai Health | 23.97M |
| Lobe Sciences | 23.77M |
| Rapid Dose Therapeutics | 14.33M |
| PreveCeutical Medical | 12.76M |
| Britannia Life Sciences | 11.52M |